Delivering Specialty Medications at the Lowest Net-Cost


The NDW Approach

Deliver Personally
We provide personalized, comprehensive patient support to drive better patient health outcomes.
Our Products

Adalimumab
Biosimilars

Ustekinumab
Biosimilars

Denosumab
Biosimilars

Tocilizumab
Biosimilars

Omalizumab
Biosimilars

Additional launches through 2026–2028
Who We Serve
- Access to lowest-net-cost specialty medications
- Transparent pricing and flexible purchasing
- EDI ordering, invoicing, and ASN support
- Cold-chain validated shipping
- Fast onboarding and reliable service
- White-label biosimilar distribution
- Exclusive or semi-exclusive sourcing models
- Integrated eligibility & claim system support
- Test claim and implementation assistance via CarePartners
- Member-level savings analytics
- Buy-and-bill support with competitive pricing
- Refrigerated shipping with same-day/next-day options
- Clinical support for onboarding and switching
- Billing/coding support through CarePartners clinical team
- Internal sourcing strategies
- Importation-aligned programs
- Real-time savings impact modeling
- Onboarding and transition support
- Biosimilar & LDD launch and scale-up support
- DSCSA-compliant national wholesale distribution for biosimilars and specialty products
- End-to-end LDN execution, from controlled access to provider enablement
- Seamless integration with specialty pharmacy services for high-touch therapies
- Immunology
- Oncology supportive care
- Rheumatology
- Gastroenterology
- Neurology
- Opthalmology (LDD)
- Rare and chronic immune disorders

Who We Serve
Manufacturers choose NDW to gain a strategic partner focused on optimized product access and accelerated adoption. We provide a unique channel that seamlessly integrates national commercial reach across PBMs, payers, and providers, with clinical excellence through CarePartners Pharmacy.
NDW builds LDD-ready, customized distribution models including open, limited, and direct-to-payer networks, to ensure the controlled and efficient delivery of sensitive therapies. By providing robust performance reporting and supporting key initiatives like biosimilar programs, we help our partners maximize market penetration and growth.
Partner with Us
Fill out the form to start a conversation with our team. All required fields are marked with *


